Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influenza Antiviral Treatment and Length of Stay.
Campbell AP, Tokars JI, Reynolds S, Garg S, Kirley PD, Miller L, Yousey-Hindes K, Anderson EJ, Oni O, Monroe M, Kim S, Lynfield R, Smelser C, Muse AT, Felsen C, Billing LM, Thomas A, Mermel E, Lindegren ML, Schaffner W, Price A, Fry AM. Campbell AP, et al. Among authors: thomas a. Pediatrics. 2021 Oct;148(4):e2021050417. doi: 10.1542/peds.2021-050417. Epub 2021 Sep 1. Pediatrics. 2021. PMID: 34470815
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Kyaw MH, et al. Among authors: thomas ar. N Engl J Med. 2006 Apr 6;354(14):1455-63. doi: 10.1056/NEJMoa051642. N Engl J Med. 2006. PMID: 16598044 Free article.
Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004.
Schrag SJ, Shay DK, Gershman K, Thomas A, Craig AS, Schaffner W, Harrison LH, Vugia D, Clogher P, Lynfield R, Farley M, Zansky S, Uyeki T; Emerging Infections Program Respiratory Diseases Activity. Schrag SJ, et al. Among authors: thomas a. Pediatr Infect Dis J. 2006 May;25(5):395-400. doi: 10.1097/01.inf.0000214988.81379.71. Pediatr Infect Dis J. 2006. PMID: 16645501
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.
Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. Whitney CG, et al. Among authors: thomas a. Lancet. 2006 Oct 28;368(9546):1495-502. doi: 10.1016/S0140-6736(06)69637-2. Lancet. 2006. PMID: 17071283
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. Hicks LA, et al. Among authors: thomas a. J Infect Dis. 2007 Nov 1;196(9):1346-54. doi: 10.1086/521626. Epub 2007 Oct 4. J Infect Dis. 2007. PMID: 17922399
Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.
Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC. Jordan HT, et al. Among authors: thomas a. Pediatr Infect Dis J. 2008 Dec;27(12):1057-64. doi: 10.1097/INF.0b013e318180b3b9. Pediatr Infect Dis J. 2008. PMID: 18989238
Evaluation of universal antenatal screening for group B streptococcus.
Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ. Van Dyke MK, et al. Among authors: thomas ar. N Engl J Med. 2009 Jun 18;360(25):2626-36. doi: 10.1056/NEJMoa0806820. N Engl J Med. 2009. PMID: 19535801 Free article.
Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States.
Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators. Lucero CA, et al. Vaccine. 2009 Aug 13;27(37):5061-8. doi: 10.1016/j.vaccine.2009.06.055. Epub 2009 Jul 2. Vaccine. 2009. PMID: 19576943
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR; Active Bacterial Core Surveillance/Emerging Infections Program Network. Pilishvili T, et al. Among authors: thomas a. J Infect Dis. 2010 Jan 1;201(1):32-41. doi: 10.1086/648593. J Infect Dis. 2010. PMID: 19947881
9,978 results